Dolby Laboratories Company Profile (NYSE:DLB)

Dolby Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "DLB."

Dolby Laboratories announced a quarterly dividend on Tuesday, July 25th. Stockholders of record on Monday, August 7th will be given a dividend of $0.14 per share on Tuesday, August 15th. This represents a $0.56 annualized dividend and a dividend yield of 0.97%. The ex-dividend date is Thursday, August 3rd. View Dolby Laboratories' Dividend History.

Dolby Laboratories declared that its Board of Directors has authorized a stock buyback program on Sunday, April 9th 2017, which permits the company to repurchase $200,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy up to 3.9% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company's board believes its stock is undervalued.

Dolby Laboratories (NYSE:DLB) issued its quarterly earnings data on Tuesday, July, 25th. The company reported $0.75 EPS for the quarter, beating the Zacks' consensus estimate of $0.65 by $0.10. The company had revenue of $305.67 million for the quarter, compared to the consensus estimate of $296.88 million. Dolby Laboratories had a return on equity of 10.25% and a net margin of 19.02%. Dolby Laboratories's quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.62 earnings per share. View Dolby Laboratories' Earnings History.

Dolby Laboratories is scheduled to release their next quarterly earnings announcement on Wednesday, October, 25th 2017. View Earnings Estimates for Dolby Laboratories.

Dolby Laboratories updated its fourth quarter earnings guidance on Tuesday, July, 25th. The company provided EPS guidance of $0.36 to $0.42 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.46. The company issued revenue guidance of $230 million to $250 million, compared to the consensus revenue estimate of $251.67 million.

5 equities research analysts have issued 12 month target prices for Dolby Laboratories' shares. Their forecasts range from $51.00 to $63.00. On average, they expect Dolby Laboratories' stock price to reach $56.88 in the next year. View Analyst Ratings for Dolby Laboratories.

Here are some recent quotes from research analysts about Dolby Laboratories stock:

• 1. According to Zacks Investment Research, "Dolby has a decent earnings surprise history, beating estimates thrice over the trailing four quarters. Presently, the company is focusing on bolstering its leadership position in audio solutions and bringing new audiovisual experiences to market to grab a greater market share. Going forward, Impressive market traction of offerings under three of its new businesses—Dolby Voice, Dolby Vision and Dolby Cinema—are expected to boost growth. Despite these positives, year to date Dolby's shares have underperformed the Zacks categorized Audio/Video Home Products industry average. Stiff competition, price-sensitive nature of the entertainment industry and fluctuations of cinema product sales pose as significant headwinds to the company’s margins. Also, fluctuations in cinema product sales and maturity of the digital cinema market might also hurt the company’s profitability." (7/4/2017)
• 2. Piper Jaffray Companies analysts commented, "We believe metrology tools will be the sweet spot in semiconductor capital spending due to the ramp of 3D chips such as FinFETS and NAND flash as well as the introduction of new materials requiring x-ray compositional analysis. u The ramps of 3D chips have been challenging for the semiconductor industry. Similarly, advanced packaging is turning to new, more complicated structures such as Through Silicon Vias (TSVs), ¼Bumps, and Copper Pillars." (1/26/2017)

Some companies that are related to Dolby Laboratories include Viacom (VIAB), World Wrestling Entertainment (WWE), Supergroup PLC (SGP), Entertainment One Ltd (ETO), Eros International PLC (EROS), DHX Media Ltd (DHXM), STV Group Plc. (STVG), Cinedigm Corp (CIDM), Bona Film Group Ltd (BONA), DTS (DTSI), FunctionX (FNCX), Lions Gate Entertainment Corp. (LGF), Pinewood Group PLC (PWS), Rentrak (RENT), Taomee Holdings Ltd (TAOM) and Twenty-First Century Fox (FOXAV).

Dolby Laboratories' management team includes the folowing people:

• Peter C. Gotcher, Independent Chairman of the Board
• Kevin J. Yeaman, President, Chief Executive Officer, Director
• Lewis Chew, Chief Financial Officer, Executive Vice President
• Mark Andrew Sherman, Executive Vice President, General Counsel, Corporate Secretary
• Robert Borchers, Senior Vice President, Chief Marketing Officer
• Steven Forshay, Senior Vice President - Advanced Technology Group
• David E. Dolby, Director
• Micheline Chau, Independent Director
• Nicholas Donatiello Jr., Independent Director
• N. William Jasper Jr., Independent Director

Dolby Laboratories' stock is owned by a variety of of institutional and retail investors. Top institutional investors include DOLBY DAGMAR (44.70%), DOLBY DAGMAR (44.20%), DOLBY DAGMAR (43.70%), Vanguard Group Inc. (4.61%), BlackRock Inc. (2.84%) and Capital World Investors (2.83%). Company insiders that own Dolby Laboratories stock include Bob Borchers, Dagmar Dolby, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, Michael Bergeron, N William Jasper, Jr, Nicholas Donatiello, Jr, Peter C Gotcher and Roger S Siboni. View Institutional Ownership Trends for Dolby Laboratories.

Dolby Laboratories' stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, Canada Pension Plan Investment Board, First Quadrant L P CA, AHL Partners LLP, Goldman Sachs Group Inc., Royce & Associates LP, JPMorgan Chase & Co. and Russell Investments Group Ltd.. Company insiders that have sold Dolby Laboratories stock in the last year include Dagmar Dolby, Kevin J Yeaman, Lewis Chew, Mark Andrew Sherman, N William Jasper, Jr and Nicholas Donatiello, Jr. View Insider Buying and Selling for Dolby Laboratories.

Dolby Laboratories' stock was acquired by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., BlackRock Inc., Timucuan Asset Management Inc. FL, Marathon Asset Management LLP, Renaissance Technologies LLC, Quantum Capital Management, American Century Companies Inc. and Vanguard Group Inc.. View Insider Buying and Selling for Dolby Laboratories.

Shares of Dolby Laboratories can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Dolby Laboratories stock can currently be purchased for approximately $57.94.